Witnessing the stock’s movement on the chart, on Wednesday, Mirum Pharmaceuticals Inc (NASDAQ: MIRM) set off with pace as it heaved 0.18% to $78.99, before settling in for the price of $78.85 at the close. Taking a more long-term approach, MIRM posted a 52-week range of $36.88-$82.58.
It was noted that the giant of the Healthcare sector posted annual sales growth of 4.14% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 4.14%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 79.75%. This publicly-traded company’s shares outstanding now amounts to $51.31 million, simultaneously with a float of $42.49 million. The organization now has a market capitalization sitting at $4.08 billion. At the time of writing, stock’s 50-day Moving Average stood at $71.35, while the 200-day Moving Average is $59.43.
Mirum Pharmaceuticals Inc (MIRM) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Mirum Pharmaceuticals Inc’s current insider ownership accounts for 17.79%, in contrast to 96.39% institutional ownership. According to the most recent insider trade that took place on Dec 22 ’25, this organization’s Director sold 5,000 shares at the rate of 80.00, making the entire transaction reach 400,000 in total value, affecting insider ownership by 0. Preceding that transaction, on Dec 19 ’25, Company’s Director sold 50,000 for 78.00, making the whole transaction’s value amount to 3,900,000. This particular insider is now the holder of 0 in total.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Trading Performance Indicators
Let’s observe the current performance indicators for Mirum Pharmaceuticals Inc (MIRM). It’s Quick Ratio in the last reported quarter now stands at 3.16. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.65. Similarly, its price to free cash flow for trailing twelve months is now 92.11.
In the same vein, MIRM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.86, a figure that is expected to reach -0.06 in the next quarter, and analysts are predicting that it will be -0.43 at the market close of one year from today.
Technical Analysis of Mirum Pharmaceuticals Inc (MIRM)
Going through the that latest performance of [Mirum Pharmaceuticals Inc, MIRM]. Its last 5-days volume of 0.4 million was inferior to the volume of 0.58 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 79.05% While, its Average True Range was 65.30.
Raw Stochastic average of Mirum Pharmaceuticals Inc (MIRM) in the period of the previous 100 days is set at 85.10%, which indicates a major rise in contrast to 81.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.15 that was higher than 2.79 volatility it exhibited in the past 100-days period.
